Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 8 de 8
Filtrar
Mais filtros








Intervalo de ano de publicação
2.
PLoS One ; 15(12): e0242749, 2020.
Artigo em Inglês | MEDLINE | ID: mdl-33264332

RESUMO

Cystic fibrosis (CF) is due to mutations in the CF-transmembrane conductance regulator (CFTR) and CF-related diabetes (CFRD) is its most common co-morbidity, affecting ~50% of all CF patients, significantly influencing pulmonary function and longevity. Yet, the complex pathogenesis of CFRD remains unclear. Two non-mutually exclusive underlying mechanisms have been proposed in CFRD: i) damage of the endocrine cells secondary to the severe exocrine pancreatic pathology and ii) intrinsic ß-cell impairment of the secretory response in combination with other factors. The later has proven difficult to determine due to low expression of CFTR in ß-cells, which results in the general perception that this Cl-channel does not participate in the modulation of insulin secretion or the development of CFRD. The objective of the present work is to demonstrate CFTR expression at the molecular and functional levels in insulin-secreting ß-cells in normal human islets, where it seems to play a role. Towards this end, we have used immunofluorescence confocal and immunofluorescence microscopy, immunohistochemistry, RT-qPCR, Western blotting, pharmacology, electrophysiology and insulin secretory studies in normal human, rat and mouse islets. Our results demonstrate heterogeneous CFTR expression in human, mouse and rat ß-cells and provide evidence that pharmacological inhibition of CFTR influences basal and stimulated insulin secretion in normal mouse islets but not in islets lacking this channel, despite being detected by electrophysiological means in ~30% of ß-cells. Therefore, our results demonstrate a potential role for CFTR in the pancreatic ß-cell secretory response suggesting that intrinsic ß-cell dysfunction may also participate in the pathogenesis of CFRD.


Assuntos
Regulador de Condutância Transmembrana em Fibrose Cística/metabolismo , Células Secretoras de Insulina/metabolismo , Adulto , Idoso , Animais , Anticorpos/metabolismo , Antígenos/metabolismo , Linhagem Celular , Regulador de Condutância Transmembrana em Fibrose Cística/imunologia , Feminino , Humanos , Lactente , Secreção de Insulina , Masculino , Camundongos , Pessoa de Meia-Idade , Ratos , Reprodutibilidade dos Testes , Adulto Jovem
3.
Sci Rep ; 9(1): 8922, 2019 06 20.
Artigo em Inglês | MEDLINE | ID: mdl-31222100

RESUMO

Research on Giardia lamblia has accumulated large information about its molecular cell biology and infection biology. However, giardiasis is still one of the commonest parasitic diarrheal diseases affecting humans. Additionally, an alarming increase in cases refractory to conventional treatment has been reported in low prevalence settings. Consequently, efforts directed toward supporting the efficient use of alternative drugs, and the study of their molecular targets appears promising. Repurposing of proton pump inhibitors is effective in vitro against the parasite and the toxic activity is associated with the inhibition of the G. lamblia triosephosphate isomerase (GlTIM) via the formation of covalent adducts with cysteine residue at position 222. Herein, we evaluate the effectiveness of omeprazole in vitro and in situ on GlTIM mutants lacking the most superficial cysteines. We studied the influence on the glycolysis of Giardia trophozoites treated with omeprazole and characterized, for the first time, the morphological effect caused by this drug on the parasite. Our results support the effectiveness of omeprazole against GlTIM despite of the possibility to mutate the druggable amino acid targets as an adaptive response. Also, we further characterized the effect of omeprazole on trophozoites and discuss the possible mechanism involved in its antigiardial effect.


Assuntos
Antiprotozoários/farmacologia , Giardia lamblia/efeitos dos fármacos , Omeprazol/farmacologia , Animais , Inibidores Enzimáticos/farmacologia , Estabilidade Enzimática , Giardia lamblia/ultraestrutura , Produtos Finais de Glicação Avançada/metabolismo , Humanos , Concentração Inibidora 50 , Cinética , Aldeído Pirúvico/metabolismo , Temperatura , Triose-Fosfato Isomerase/antagonistas & inibidores , Triose-Fosfato Isomerase/metabolismo
4.
Sci Rep ; 7(1): 17231, 2017 12 08.
Artigo em Inglês | MEDLINE | ID: mdl-29222447

RESUMO

Cystic fibrosis (CF)-related diabetes (CFRD) is thought to result from beta-cell injury due in part to pancreas exocrine damage and lipofibrosis. CFRD pancreata exhibit reduced islet density and altered cellular composition. To investigate a possible etiology, we tested the hypothesis that such changes are present in CF pancreata before the development of lipofibrosis. We evaluated pancreas and islet morphology in tissues from very young CF children (<4 years of age), and adult patients with CF and CFRD. The relative number of beta-cells in young CF tissues was reduced by 50% or more when compared to age-matched controls. Furthermore, young CF tissues displayed significantly smaller insulin-positive areas, lower proportion of beta-cells positive for the proliferation marker Ki67 or the ductal marker CK19 vs. control subjects, and islet inflammatory cell infiltrates, independently of the severity of the exocrine lesion and in the absence of amyloid deposits. CFRD pancreata exhibited greater islet injury with further reduction in islet density, decreased relative beta-cell number, and presence of amyloid deposits. Together, these results strongly suggest that an early deficiency in beta-cell number in infants with CF may contribute to the development of glucose intolerance in the CF pediatric population, and to CFRD, later in life.


Assuntos
Fibrose Cística/patologia , Complicações do Diabetes/patologia , Ilhotas Pancreáticas/patologia , Proliferação de Células , Pré-Escolar , Fibrose Cística/metabolismo , Complicações do Diabetes/metabolismo , Feminino , Teste de Tolerância a Glucose , Humanos , Insulina/metabolismo , Ilhotas Pancreáticas/metabolismo , Masculino , Pâncreas Exócrino/metabolismo , Pâncreas Exócrino/patologia
5.
Blood ; 122(18): 3101-10, 2013 Oct 31.
Artigo em Inglês | MEDLINE | ID: mdl-23982171

RESUMO

Hydroa vacciniforme-like lymphoma (HVLL) is an Epstein-Barr virus (EBV)-positive T-cell lymphoproliferative disorder of childhood that occurs mainly in Central and South America and Asia. We present the clinicopathological features of 20 Mexican children with HVLL with a median age of 8 years at diagnosis (range, 1-15). All patients presented with skin lesions involving sun-exposed areas, but not exclusively. Fever, lymphadenopathy, and hepatosplenomegaly were often observed. Most patients were treated with immunomodulators and/or immunosuppressive agents, resulting in temporary remission. For 13 patients follow-up was available for a median of 3 years (range, 1 month-13 years). Three patients with long follow-up (9-13 years) are alive with disease. Four patients died, 2 after developing systemic lymphoma. Histologically, the skin showed a predominantly angiocentric and periadnexal Epstein-Barr early RNA+ lymphoid infiltrate with variable atypia and subcutaneous involvement. Fifteen patients showed a T-cell phenotype (12, αß; 2, γδ; 1, silent phenotype) and monoclonal T-cell receptor-γ rearrangements, whereas 6 exhibited a natural killer (NK)-cell phenotype. Four patients had hypersensitivity to mosquito bites. One patient showed both phenotypes. HVLL is an EBV-associated lymphoproliferative disorder of αß-, γδ-, or NK-cell phenotype with a broad clinical spectrum, usually prolonged clinical course, and risk for progression to systemic disease.


Assuntos
Infecções por Vírus Epstein-Barr/patologia , Hidroa Vaciniforme/patologia , Linfoma Cutâneo de Células T/patologia , Transtornos Linfoproliferativos/patologia , Adolescente , Criança , Pré-Escolar , Infecções por Vírus Epstein-Barr/complicações , Infecções por Vírus Epstein-Barr/tratamento farmacológico , Feminino , Seguimentos , Herpesvirus Humano 4/efeitos dos fármacos , Herpesvirus Humano 4/genética , Herpesvirus Humano 4/metabolismo , Humanos , Hidroa Vaciniforme/complicações , Hidroa Vaciniforme/tratamento farmacológico , Imuno-Histoquímica , Imunossupressores/uso terapêutico , Hibridização In Situ , Lactente , Linfoma Cutâneo de Células T/complicações , Linfoma Cutâneo de Células T/tratamento farmacológico , Transtornos Linfoproliferativos/complicações , Transtornos Linfoproliferativos/tratamento farmacológico , Masculino , México , RNA Viral/genética , Receptores de Antígenos de Linfócitos T/genética , Esteroides/uso terapêutico , Linfócitos T/efeitos dos fármacos , Linfócitos T/metabolismo , Linfócitos T/virologia , Talidomida/uso terapêutico , Proteínas Virais/metabolismo
6.
Neuropathology ; 24(1): 30-7, 2004 Mar.
Artigo em Inglês | MEDLINE | ID: mdl-15068170

RESUMO

A convenient transgenic astrocytoma model in delta202 mice, homozygous for a construct encoding the early region of the SV40 virus genome, is described. In the offspring of crosses between delta202 mice heterozygous for the transgene nearly 60% were transgenic; one third of these developed progressive paralysis starting in the hindlimbs at approximately 35 days of age and died at 90 +/- 30 days of age. In affected mice proliferating-non-neuronal cells immunostained with antibodies to the GFAP, an astrocyte marker, whose number increased with age were found in the white matter of the brain, cerebellum and spinal cord, and progressive degeneration and necrosis of spinal motoneurons was observed that-may explain the paralysis. The early onset and reproducible time course of the neurological disease suggest that homozygous delta202 mice, whose proliferating astrocytes appear to damage spinal motoneurons, are a useful model to study astrocyte differentiation, function and tumorigenesis.


Assuntos
Antígenos Transformantes de Poliomavirus/genética , Astrócitos/patologia , Homozigoto , Paralisia/genética , Paralisia/patologia , Anaplasia , Animais , Astrócitos/virologia , Astrocitoma/genética , Astrocitoma/virologia , Osso e Ossos/patologia , Osso e Ossos/virologia , Progressão da Doença , Feminino , Masculino , Camundongos , Camundongos Endogâmicos BALB C , Camundongos Endogâmicos DBA , Camundongos Transgênicos , Músculo Esquelético/patologia , Músculo Esquelético/virologia , Paralisia/virologia
8.
Acta pediátr. Méx ; 6(1): 3-7, ene.-mar.
Artigo em Espanhol | LILACS | ID: lil-27902

RESUMO

Se hace un análisis de los resultados de la bacteriología en estudios postmortem señalando las etapas por las que ha cursado en lo que respecta a su importancia y significado clínico. Se mencionan también los diferentes trabajos en los que se hace hincapié, en los conceptos de invasión bacteriana agónica, preagónica, transmigración y microflora indígena, en los que los diferentes autores no se ponen de acuerdo en su significado. La bacteriología postmortem debe ser interpretada con cuidado, siguiendo una metodología particular para la toma y manejo de las muestras, para el cultivo bacteriológico y el resultado debe ser interpretado con cautela integrando la información clínica y la alteración tisular


Assuntos
Humanos , Bactérias/isolamento & purificação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA